share_log

长光华芯:预计今年全年收入与去年持平 正开发激光医疗和医美相关产品|直击业绩会

Changguang Huaxin: It is expected that this year's annual revenue will be on par with last year, actively developing laser medical and medical beauty related products|Directly focusing on the earnings conference

cls.cn ·  Oct 8 18:40

①Changguang Huaxin is expanding its radar and optical communication business, which is expected to contribute to revenue in Q4 this year; ②The company has laid out in the industrial laser and sensor fields, actively developing laser medical and medical beauty related products.

"Star Daily" news on October 8th (Reporter Huang Xiumei) "Affected by factors such as the slowdown in global economic growth, the overall demand for lasers is weak. Based on the current economic situation, global strategy layout, and product progress, the company expects that the full-year revenue in 2024 will maintain the same level as last year (29 million yuan). Changguang Huaxin Chairman and General Manager Min Dayong stated at the 2024 half-year performance briefing."

Changguang Huaxin focuses on the semiconductor laser industry, focusing on the research and development, manufacturing, and sales of core components of the semiconductor laser industry such as semiconductor laser chips, devices, and modules.

From an operational perspective, from the second quarter of 2023 to the second quarter of this year, the company has incurred losses for five consecutive single quarters, and the net income attributable to shareholders in each of the above quarters has all decreased significantly year-on-year.

In response to this, Min Dayong responded to investors' questions at today's (October 8) performance briefing, saying: "In response to the losses in the past two years, the company is working hard to implement various countermeasures and actively explore the market."

0OML96j42q.png

(Changguang Huaxin quarterly revenue situation)

4UAyf77ev3.png

(Changguang Huaxin's quarterly net income attributable to the parent company)

In terms of exploring new markets, Changguang Huaxin has increased its focus on the optical communication field dominated by datacenters in recent years, launching three major categories of new products: VCSEL, EML, and DFB. "The verification of these three products by domestic leading optical module manufacturers is good," said Min Dayong.

Min Dayong also stated, "Although the proportion of automotive lidar is small, technological convergence is nearing completion, which is conducive to mass production. It is expected that there may be revenue contributions in the fourth quarter of this year in the radar and optical communication fields."

The reporter from the Star Market Daily noticed that Changguang Huaxin has increased its external investment efforts while laying out semiconductor laser technology in recent years.

Min Dayong stated that the company has already laid out in the industrial laser and sensor fields, and is currently actively developing laser medical and medical beauty related products. "We hope to leverage the advantages of semiconductor laser chips covering the full spectrum in the health industry, achieving medical and consumer electronics in medical aesthetics."

Changguang Huaxin also stated in an investor survey in September of this year that the company is also planning to invest in the field of laser medical and medical aesthetics.

It is worth mentioning that among the relevant companies in the laser field of the Star Market, including Hymson Laser Technology Group, Juguang Technology, etc., all have clearly stated that they are actively laying out the laser medical aesthetics sector this year.

Among them, Hymson Laser Technology Group stated in an investor survey on September 18 this year that the company is currently advancing the application for Class II and Class III medical device certificates for related products. Among the indications for Class III medical devices, the fastest commercialization can be achieved in products related to hair regeneration and collagen regeneration, which are currently undergoing relevant clinical trials.

Hymson Laser Technology Group's related products have been applied in the areas of skin rejuvenation, tender skin, and fat dissolution. It previously announced an international patent application named "Spot Shaping Device and Laser Processing Equipment", with an international publication date of June 13 this year.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment